nodes	percent_of_prediction	percent_of_DWPC	metapath
Hexylcaine—SCN10A—skin cancer	0.986	1	CbGaD
Hexylcaine—Cocaine—SCN10A—skin cancer	0.00247	1	CrCbGaD
Hexylcaine—SCN3A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00158	0.14	CbGpPWpGaD
Hexylcaine—SCN2A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00151	0.135	CbGpPWpGaD
Hexylcaine—SCN1A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00146	0.13	CbGpPWpGaD
Hexylcaine—SCN5A—Interaction between L1 and Ankyrins—SCN10A—skin cancer	0.00103	0.0913	CbGpPWpGaD
Hexylcaine—SCN3A—L1CAM interactions—SCN10A—skin cancer	0.000605	0.0538	CbGpPWpGaD
Hexylcaine—SCN2A—L1CAM interactions—SCN10A—skin cancer	0.000581	0.0517	CbGpPWpGaD
Hexylcaine—SCN1A—L1CAM interactions—SCN10A—skin cancer	0.00056	0.0498	CbGpPWpGaD
Hexylcaine—SCN5A—L1CAM interactions—SCN10A—skin cancer	0.000394	0.035	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—SCN10A—skin cancer	0.000229	0.0203	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—SCN10A—skin cancer	0.00022	0.0195	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—SCN10A—skin cancer	0.000212	0.0188	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—SCN10A—skin cancer	0.000163	0.0145	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—SCN10A—skin cancer	0.000157	0.0139	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—SCN10A—skin cancer	0.000151	0.0134	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—SCN10A—skin cancer	0.000149	0.0132	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—RASA1—skin cancer	0.000131	0.0117	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—RASA1—skin cancer	0.000126	0.0112	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—RASA1—skin cancer	0.000122	0.0108	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—RASA1—skin cancer	0.000122	0.0108	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—SCN10A—skin cancer	0.000106	0.00945	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—RASA1—skin cancer	9.37e-05	0.00833	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—RASA1—skin cancer	9e-05	0.008	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—RASA1—skin cancer	8.68e-05	0.00772	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—RASA1—skin cancer	8.68e-05	0.00772	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—RASA1—skin cancer	8.55e-05	0.0076	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—RASA1—skin cancer	6.1e-05	0.00543	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—CDK4—skin cancer	4.59e-05	0.00409	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—CDK4—skin cancer	4.41e-05	0.00393	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—CDK4—skin cancer	4.26e-05	0.00378	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—CDK4—skin cancer	4.26e-05	0.00378	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—NRAS—skin cancer	3.58e-05	0.00318	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—NRAS—skin cancer	3.44e-05	0.00306	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—NRAS—skin cancer	3.32e-05	0.00295	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—NRAS—skin cancer	3.32e-05	0.00295	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—KRAS—skin cancer	3.08e-05	0.00274	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—CDK4—skin cancer	2.99e-05	0.00266	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—KRAS—skin cancer	2.96e-05	0.00263	CbGpPWpGaD
Hexylcaine—SCN5A—SIDS Susceptibility Pathways—IL6—skin cancer	2.93e-05	0.00261	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—KRAS—skin cancer	2.85e-05	0.00254	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—KRAS—skin cancer	2.85e-05	0.00254	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—HRAS—skin cancer	2.62e-05	0.00233	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—NRAS—skin cancer	2.56e-05	0.00227	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—HRAS—skin cancer	2.52e-05	0.00224	CbGpPWpGaD
Hexylcaine—SCN3A—Axon guidance—IL6—skin cancer	2.51e-05	0.00223	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—NRAS—skin cancer	2.45e-05	0.00218	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—HRAS—skin cancer	2.43e-05	0.00216	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—HRAS—skin cancer	2.43e-05	0.00216	CbGpPWpGaD
Hexylcaine—SCN2A—Axon guidance—IL6—skin cancer	2.41e-05	0.00214	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—NRAS—skin cancer	2.37e-05	0.0021	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—NRAS—skin cancer	2.37e-05	0.0021	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—NRAS—skin cancer	2.33e-05	0.00207	CbGpPWpGaD
Hexylcaine—SCN10A—Axon guidance—IL6—skin cancer	2.32e-05	0.00207	CbGpPWpGaD
Hexylcaine—SCN1A—Axon guidance—IL6—skin cancer	2.32e-05	0.00207	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—KRAS—skin cancer	2.2e-05	0.00196	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—KRAS—skin cancer	2.11e-05	0.00188	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—KRAS—skin cancer	2.04e-05	0.00181	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—KRAS—skin cancer	2.04e-05	0.00181	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—KRAS—skin cancer	2.01e-05	0.00178	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—HRAS—skin cancer	1.87e-05	0.00166	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—HRAS—skin cancer	1.8e-05	0.0016	CbGpPWpGaD
Hexylcaine—SCN3A—Developmental Biology—IL6—skin cancer	1.79e-05	0.00159	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—HRAS—skin cancer	1.73e-05	0.00154	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—HRAS—skin cancer	1.73e-05	0.00154	CbGpPWpGaD
Hexylcaine—SCN2A—Developmental Biology—IL6—skin cancer	1.72e-05	0.00153	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—HRAS—skin cancer	1.71e-05	0.00152	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—NRAS—skin cancer	1.66e-05	0.00148	CbGpPWpGaD
Hexylcaine—SCN1A—Developmental Biology—IL6—skin cancer	1.66e-05	0.00147	CbGpPWpGaD
Hexylcaine—SCN10A—Developmental Biology—IL6—skin cancer	1.66e-05	0.00147	CbGpPWpGaD
Hexylcaine—SCN5A—Axon guidance—IL6—skin cancer	1.63e-05	0.00145	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—KRAS—skin cancer	1.43e-05	0.00127	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—HRAS—skin cancer	1.22e-05	0.00108	CbGpPWpGaD
Hexylcaine—SCN5A—Developmental Biology—IL6—skin cancer	1.17e-05	0.00104	CbGpPWpGaD
